Astellas has established a Focus Area Approach for its research and development strategy. Specifically, our Focus Area Strategy is defined as combinations of three components: (1) biologies with high disease relevance, (2) versatile modalities/technologies, and (3) diseases with high unmet medical needs that are expected to be tackled by the first two components. We view this strategy as a way to build a sustainable, expandable drug discovery approach to develop new platforms, leverage expertise and create innovative products. We also focus on the cutting-edge technology such as cell therapy and gene therapy, and work on providing innovative healthcare treatments which can address the root cause of the diseases.
Message from R&D team
*Agile organization: An organization in which members with various expertise get together to iterate by trial and error to continuously improve solutions. There, highly delegated mission-specific units make quick decisions and act autonomously.